9-[4-(DIBROMOMETHYLDIPHOSPHONYLOXY)-OXYPHOSPHONYLMETHOXY)-CYCLOPENT-2-ENYL]-GUANINE
Compound with spectra: 1 NMR
![9-[4-(DIBROMOMETHYLDIPHOSPHONYLOXY)-OXYPHOSPHONYLMETHOXY)-CYCLOPENT-2-ENYL]-GUANINE](/api/compound/18oNfL2gytB.png?ph=true&h=300&w=458 "9-[4-(DIBROMOMETHYLDIPHOSPHONYLOXY)-OXYPHOSPHONYLMETHOXY)-CYCLOPENT-2-ENYL]-GUANINE")
| SpectraBase Compound ID | 18oNfL2gytB |
|---|---|
| InChI | InChI=1S/C12H16Br2N5O10P3/c13-12(14,31(23,24)25)32(26,27)29-30(21,22)5-28-7-2-1-6(3-7)19-4-16-8-9(19)17-11(15)18-10(8)20/h1-2,4,6-7H,3,5H2,(H,21,22)(H,26,27)(H2,23,24,25)(H3,15,17,18,20)/t6-,7+/m0/s1 |
| InChIKey | KFOMNNQJNYXTAZ-NKWVEPMBSA-N |
| Mol Weight | 643.01 g/mol |
| Molecular Formula | C12H16Br2N5O10P3 |
| Exact Mass | 640.847679 g/mol |
| Enantiomer InChIKey | KFOMNNQJNYXTAZ-RQJHMYQMSA-N |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | D2O |
9-[4-(DIFLUOROMETHYLDIPHOSPHONYL)-OXYPHOSPHONYLMETHOXY)-CYCLOPENT-2-ENYL]-GUANINE
(1'S,4'R)-9-[4'-(HYDROXY)-[[(DIFLUORO)-(PHOSPHONO)-METHYL]-HYDROXYPHOSPHORYLOXY]-PHOSPHORYLMETHOXY)-CYCLOPENT-2'-ENYL]-GUANINE-(TRIS-AMMONIUM-SALT)
(1'S,4'R)-9-[4'-(HYDROXY-([(DIFLUORO)-(METHYLHYDROXYPHOSPHORYL)-METHYL]-HYDROXYPHOSPHORYLOXY)-PHOSPHORYLMETHOXY)-CYClOPENT-2'-ENYL]-GUANINE-(TRIS-A
3',5'-(TERT.-BUTYLDIMETHYLSILYLOXY)-2'-DEOXYGUANOSINE
3',5'-DI-O-LEVULINYL-2'-DEOXYGUANOSINE
[(2R,3S,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3-butanoyloxy-tetrahydrofuran-2-yl]methyl butanoate
GUANOSINE 5'-PHOSPHATE, DISODIUM SALT, MONOHYDRATE
Guanosine 5'-monophosphate disodium salt hydrate
[(2S,3R,4S,5S)-5-(2-amino-6-keto-3H-purin-9-yl)-3,4-dihydroxy-tetrahydrofuran-2-yl]methoxy-trihydroxy-phosphonium
deoxy-N-acetyl-2-amino-9.beta.- D-(diacetyl)ribofuranosyl)-9H-purine-6(1H)-one
| Title | Journal or Book | Year |
|---|---|---|
| Carbocyclic Dinucleoside Polyphosphonates: Interaction with HIV Reverse Transcriptase and Antiviral Activity | Journal of Medicinal Chemistry | 2002 |